Skip to main content
Premium Trial:

Request an Annual Quote

Short Reads: Feb 1, 2002

Premium

Hoping to expand its genomics turf to include a drug bent, Lexicon Genetics names the former director of biotechnology licensing at Bristol- Myers Squibb’s Pharmaceutical Research Institute, Stephen McAndrew, to the position of vice president of pharmaceutical business development.

 

Sequenom got jiggy with its staff. Andreas Braun, current chief medical officer, will kick off the new pharmaceuticals unit. Jay Lichter joins as executive vice president of business development from previous posts at Pfizer and Genset. And in the promotions department: Rick Episcopo moves to executive VP of commercial operations and will lead the genetic systems business unit. Tristan Orpin becomes veep of corporate S&M … that is, sales and marketing. Charles Rodi gets bumped up to executive VP of genomics and will lead the company’s genotyping center. And Richard Macdonald

is promoted to SVP of corporate research and development. Hey, maybe they got a discount on new business cards.

 

MDS Proteomics hires Anil Amlani as its new CFO. Amlani comes to the proteomics field from Cancom, Canadian Satellite Communications.

 

Peter Horn moves up to VP for business development from his old position of CFO at Nautilus Biotech. Horn expects to move soon from the office in Paris to the one in San Diego.

Molly Schmid, last seen in charge of bioinformatics and functional genomics at Genencor, is now the senior vice president of antibacterial pharmaceuticals and alliances at Integrative Proteomics in Toronto.

 

Ronald Griffith heads to Genelabs Technologies in Redwood City, Calif., as vice president of research. From Isis Pharmaceuticals, he will direct the company’s efforts to optimize drug candidates targeting microbial DNA.

 

Deltagen’s genomics R&D center in Strasbourg, France, will be led by new scientific director Majid Mehtali. Deltagen Europe is scheduled to be completed in 2003.

 

Brad Walsh alerted people in January that he''d resigned from his position as facility manager at APAF, the Australian Proteome Analysis Facility.

 

Tragically, bioinformatics researcher Robert Schwartz was found dead in his Virginia home two weeks before Christmas. Apparently the victim of a slaying, Schwartz, 57, was executive director for R&D and university relations at Virginia’s Center for Innovative Technology and was a founding member of the Virginia Biotechnology Association. He is also remembered as a leader in the industrial consortium out of Georgetown University that created the first national online database of DNA sequence information.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.